Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

SELL
$15.75 - $21.38 $93,507 - $126,933
-5,937 Reduced 2.58%
224,069 $4.7 Million
Q3 2023

Nov 14, 2023

SELL
$20.22 - $27.36 $4.97 Million - $6.73 Million
-245,919 Reduced 51.67%
230,006 $4.89 Million
Q2 2023

Aug 14, 2023

SELL
$19.39 - $28.9 $377,562 - $562,740
-19,472 Reduced 3.93%
475,925 $12.8 Million
Q1 2023

May 15, 2023

SELL
$12.71 - $21.17 $89,313 - $148,761
-7,027 Reduced 1.4%
495,397 $9.74 Million
Q4 2022

Feb 14, 2023

BUY
$11.23 - $19.44 $89,020 - $154,100
7,927 Added 1.6%
502,424 $6.83 Million
Q3 2022

Nov 14, 2022

SELL
$12.2 - $18.71 $81,642 - $125,207
-6,692 Reduced 1.34%
494,497 $8.76 Million
Q2 2022

Aug 15, 2022

BUY
$12.05 - $22.74 $612,682 - $1.16 Million
50,845 Added 11.29%
501,189 $6.12 Million
Q1 2022

May 16, 2022

BUY
$18.32 - $23.03 $1.09 Million - $1.37 Million
59,484 Added 15.22%
450,344 $9.73 Million
Q4 2021

Feb 14, 2022

BUY
$18.75 - $24.8 $267,150 - $353,350
14,248 Added 3.78%
390,860 $8.75 Million
Q3 2021

Nov 15, 2021

BUY
$19.65 - $31.89 $1.44 Million - $2.34 Million
73,319 Added 24.17%
376,612 $8.07 Million
Q2 2021

Aug 16, 2021

BUY
$29.4 - $35.96 $8.92 Million - $10.9 Million
303,293 New
303,293 $9.54 Million

Others Institutions Holding SIBN

About SI-BONE, Inc.


  • Ticker SIBN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 34,305,000
  • Market Cap $446M
  • Description
  • SI-BONE, Inc., a medical device company, develops implantable devices used to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers iFuse, a minimally invasive surgical implant system to address sacroiliac joint dysfunction and degeneration, adult deformity, and pelvic ring traumatic fract...
More about SIBN
Track This Portfolio

Track Amundi Portfolio

Follow Amundi and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Amundi, based on Form 13F filings with the SEC.

News

Stay updated on Amundi with notifications on news.